Claritev Corporation · NYSE:CTEV
Claritev — J.P. Morgan 44th Annual Healthcare Conference (January 2026)
28 slides from Claritev's conference presentation, Jan 15, 2026
Slide 1: Claritev J.P. Morgan 44th Annual Healthcare Conference
1 January 15, 2026 Claritev J.P. Morgan 44th Annual Healthcare Conference NYSE: CTEV
Slide 2: Presenters
2 Presenters President & CEO Travis Dalton CFO Doug Garis
Slide 3: Disclaimers: Forward-Looking Statements
3 Disclaimers Forward-Looking Statements This presentation includes statements that express our management’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements
Slide 4: Agenda
4 01 Claritev Vision 02 Products and Offerings Agenda 03 Financial Overview
Slide 5: Claritev Vision
& claritev Claritev Vision
Slide 6: Our purpose is to make healthcare transparent and affordable for all
6 Our purpose is simple. We work to help make healthcare transparent and affordable for all.
Slide 7: Our Mission in Action
7 Our Mission in Action $24.7B Potential Savings Identified 60M Health Plan Members Served* >100K Employers/Plan Sponsors Served* 1.4M Providers Under Contract 700+ Insurance carriers, plan admins and other payor clients $177.6B Claim Charges Processed For more than 40 years, Claritev has been deliv
Slide 8: Our Journey
8 Our Journey THE FOUNDATION and THE VISION Clarity | Alignment | Focus, Fit for Growth, Horizons THE TURN Launch Brand, New Products, Business Models, Markets THE WAY UP Focus and Disciplined Execution, Sales Aggression, Growth THE WAY FORWARD Sustained Growth, Independence, Culture, Product, Acqui
Slide 9: Market Challenges
9 Market Challenges Escalating Healthcare Costs and Inflation Employer Costs Rising, Shifting to Employees Complexity of Regulatory Compliance Consumer Demand for Transparency & Personalization Fragmentation, Waste & Inefficiencies in Care Coordination 8.5% Medical Inflation 8-10% Healthcare cost in
Slide 10: The Vision
10 The Vision To Make Healthcare More Transparent and Affordable for All Patients Payors | TPA Brokers | Employers Government Channel Partners (e.g., Oracle) Providers International Enterprise Data Platform Data Warehouse | AI/ML | Language Models Technical Infrastructure Oracle Cloud Infrastructure
Slide 11: Where Our Transformation Leads Us
11 Where Our Transformation Leads Us World-Class Talent and Leadership with Growth Mindset Serving the Entire Healthcare Continuum Sustainable Growth Diversified Business Model and Product Suite Organic Product Capability Leading with Data, Analytics and Technology Capital Structure that Fits the Bu
Slide 12: Products and Offerings
& claritev Products and Offerings Sa
Slide 13: Network, Claims Intelligence and Payment Integrity Solutions
13 Build and manage custom healthcare provider networks with access to 1.4M credentialed providers Data-driven reimbursement solutions for out-of-network claims & support for NSA compliance Identify, correct and prevent improper billing to optimize accuracy and reduce waste and abuse in the healthca
Slide 14: Marketplace Aligned
14 Marketplace Aligned Our products and services are offered across multiple marketplaces and distribution channels Claims Intelligence Payment & Revenue Integrity Network Vistara Data & Analytics Existing New Entry Emerging Revenue/business concentration has historically been here Payors | TPA Brok
Slide 15: Vistara Expansion Initiatives Can Double Our Addressable Market
15 Vistara Expansion Initiatives Can Double Our Addressable Market $14-18B CORE VERTICALS EXPANSION AREAS • OON Analytics $3- 4B • Provider Networks $5-6B • Payment & Revenue Integrity $6-8B Alternative Employer Networks Payor & Provider Analytics Data & Analytics Solutions Network Solutions Claims
Slide 16: Multi-Pronged Approach to Accelerate Growth
16 Multi-Pronged Approach to Accelerate Growth 04 03 02 01 Grow the Core Tailored focus and proactive engagement with existing clients Penetrate New Market Verticals Entry into Provider and International Accelerate Product Innovation Pursue big swings and ideas to solve global healthcare problems Ad
Slide 17: Why Claritev: Our Competitive Advantage
17 Proprietary data & analytics 400k custom business rules derived from 700+ payors and over 40 years of experience and claims flow Extensive technology scale Managing 15+ petabytes of data and ingesting 500B+ records monthly High provider acceptance Our solutions minimize provider abrasion and achi
Slide 18: Financial Overview
& claritev Financial Overview
Slide 19: Quarterly Results Demonstrate Success in Year of the Turn
19 Quarterly Results Demonstrate Success in Year of the Turn Revenue and EBITDA by Quarter ($ in millions) 236.6 238.0 242.8 244.1 234.5 233.5 230.5 232.1 231.3 241.6 246.0 156.3 152.7 152.3 156.8 146.8 146.7 141.6 141.6 142.1 154.0 155.1 $0 $25 $50 $75 $100 $125 $150 $175 $200 $225 $250 Q1 '23 Q2 '
Slide 20: Claritev PSAV Normalized Analysis - Rate/Volume/Mix
20 Claritev PSAV Normalized Analysis* - Rate/Volume/Mix Rate/Vol/Mix ($M’s) - Revenue per Claim Analysis $15 $(9) FY25 Q2 Rate & Mix Volume FY25 Q3 $199 $205 + $6 (+3.0%) 3,740 3,784 3,609 3,546 3,314 3,273 3,129 0 1,000 2,000 3,000 4,000 5,000 6,000 FY24 Q1 FY24 Q2 FY24 Q3 FY24 Q4 FY25 Q1 FY25 Q2 F
Slide 21: Strategic Investment Prioritization and Capital Allocation
21 Our primary use of capital is invest in our business, serve our clients, care for our associates, and maximize shareholder value. HIGHEST PRIORITYOrganic investments to fuel Vision 2030 Plan Debt paydown Value creating M&A Share buybacks HIGH PRIORITY HIGH PRIORITY LOW % OF CAPITAL ALLOCATION Str
Slide 22: Claritev Has Been Re-Invigorated and is Positioned to Accelerate Growth
22 Claritev has Been Re-Invigorated and is Positioned to Accelerate Growth 6 2 3 1 4 5 Recurring Revenue from a Durable, Proven and Highly Profitable1 Core Business Automated claims processing volume and integrated offering increases predictable revenue Multiple Avenues to Drive Growth from New Prod
Slide 23: Thank you
@3 claritev” Thank you
Slide 24: Appendix
@3 claritev” Appendix
Slide 25: Balance Sheet
25 Balance Sheet $ in millions DEBT STRUCTURE (Outstanding Principal Balances) 9/30/2025 Rate Maturity 2025 Revolving Credit Facility $ 70 SOFR+3.75% DEC-29 New First-Out First Lien Term Loans 323 SOFR+3.75% DEC-30 New Second-Out First Lien Term Loans 1,138 SOFR+4.60%+CSA1 DEC-30 New Second-Out Firs
Slide 26: Reconciliation of GAAP and Non-GAAP Items
26 Reconciliation of GAAP and Non-GAAP Items $ in thousands, except share data (1"Other expenses, net" represents miscellaneous non-recurring expenses, impairment of other assets, non-integration related severance costs, legal expenses associated with the multi-district litigation, and start-up cost
Slide 27: Reconciliation of GAAP and Non-GAAP Items, continued
27 Reconciliation of GAAP and Non-GAAP Items, continued $ in thousands, except share data (1"Other expenses, net" represents miscellaneous non-recurring expenses, impairment of other assets, non-integration related severance costs, legal expenses associated with the multi-district litigation, and st
Slide 28: Reconciliation of GAAP and Non-GAAP Items, continued
28 Reconciliation of GAAP and Non-GAAP Items, continued $ in thousands, except share data (1"Other expenses, net" represents miscellaneous non-recurring expenses, impairment of other assets, non-integration related severance costs, legal expenses associated with the multi-district litigation, and st
Claritev — J.P. Morgan 44th Annual Healthcare Conference (January 2026) on 6ix